MA Full Risk
Humana MA Global Cap
Quality within 5 pts of gate
Attributed lives
5,280
MLR
88.5%
$1098 spend vs $1240 revenue PMPM
Quality score
84
Gate 80
Projected settlement
$9.0M
Downside exposure $78.6M
Contract terms
- Payer
- Humana
- Arrangement
- Global capitation (% of premium)
- Risk
- Full Risk
- Period
- CY2026
- Cap revenue
- $1240 PMPM
- Surplus share
- 100%
- Quality gate
- 80
Data completeness
87%
Claims through 2026-09-30. Recent months completed with IBNR estimates.
PMPM spend vs cap revenue
Dashed = IBNR-estimated monthsQuality measures
Marker = targetControlling High BP
70% / 70%
Met
Diabetes HbA1c <9
76% / 75%
Met
Breast Cancer Screening
75% / 74%
Met
Colorectal Screening
68% / 68%
Met
Med Adherence – Statins
90% / 88%
Met
Utilization
- Admits / 1000
- 210
- ED / 1000
- 540
- Readmit %
- 13.9
- SNF days / 1000
- 870
Risk adjustment
1.31
▲ 0.05 vs prior year (1.26)
RAF drives benchmark / premium — falling RAF shrinks revenue.